Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HVIVO PLC Board/Management Information 2015

Jun 15, 2015

7697_rns_2015-06-15_7f7afe66-ce83-468b-8e74-39474a589011.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1045Q

Venn Life Sciences Holdings PLC

15 June 2015

Venn Life Sciences Holdings Plc

("Venn" or the "Company" or the "Group")

Appointment of Chief Financial Officer

On 12 May 2015, Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announced the appointment of Jonathan Hartshorn as Chief Financial Officer with effect from 15th June 2015.

The Company is pleased to confirm that Jonathan will begin his duties in that role today.

The Company reaffirms that save as disclosed in the announcement of 12 May 2015, there are no other disclosures required in relation to paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Enquiries:

Venn Life Sciences Holdings Plc www.vennlifesciences.com
Tony Richardson, Chief Executive Officer Tel: +353 154 99 341
Orla Mc Guinness, Marketing Manager Tel: +33 676 93 11 78
Zeus Capital (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones Tel: 0161 831 1512
Alex Davies Tel: 020 7533 7727
Walbrook PR Ltd Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus Mob: +44 (0)7980 541 893
Lianne Cawthorne Mob: +44 (0)7584 391 303

About Venn Life Sciences Limited:

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCBIGDLCUBBGUS